According to the latest data from the Hong Kong Stock Exchange, on July 7th, investment manager China Universal Asset Management Co., Ltd. reduced its holding in CSPC PHARMA (HKEX: 01093) by 1.936 million shares.
The transaction was executed at an average price of approximately HK$8.0008 per share, resulting in a total consideration of about HK$15.4895 million.
Following this disposal, the firm's latest shareholding stands at approximately 575 million shares, representing a stake of 4.98% in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments